Home
>
National Drug Code (NDC)
>
Ciprofloxacin
Ciprofloxacin - 0069-3241-22 - (Ciprofloxacin)
Drug Information of Ciprofloxacin
| Product NDC: | 0069-3241 |
| Proprietary Name: | Ciprofloxacin |
| Non Proprietary Name: | Ciprofloxacin |
| Active Ingredient(s): | 10 mg/mL & nbsp; Ciprofloxacin |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION, CONCENTRATE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Ciprofloxacin
| Product NDC: | 0069-3241 |
| Labeler Name: | Pfizer Labs, Division of Pfizer Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA078062 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20090911 |
Package Information of Ciprofloxacin
| Package NDC: | 0069-3241-22 |
| Package Description: | 10 CARTON in 1 CASE (0069-3241-22) > 1 VIAL in 1 CARTON (0069-3241-15) > 20 mL in 1 VIAL |
NDC Information of Ciprofloxacin
| NDC Code | 0069-3241-22 |
| Proprietary Name | Ciprofloxacin |
| Package Description | 10 CARTON in 1 CASE (0069-3241-22) > 1 VIAL in 1 CARTON (0069-3241-15) > 20 mL in 1 VIAL |
| Product NDC | 0069-3241 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Ciprofloxacin |
| Dosage Form Name | INJECTION, SOLUTION, CONCENTRATE |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20090911 |
| Marketing Category Name | ANDA |
| Labeler Name | Pfizer Labs, Division of Pfizer Inc |
| Substance Name | CIPROFLOXACIN |
| Strength Number | 10 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Quinolone Antimicrobial [EPC],Quinolones [Chemical/Ingredient] |
